INVESTIGATING THE EFFICACY AND SAFETY OF SGLT2 INHIBITORS FOR CARDIOVASCULAR PROTECTION IN PATIENTS WITH OBESITY AND TYPE 2 DIABETES. (2025). The Research of Medical Science Review, 3(4), 307-312. http://www.thermsr.com/index.php/Journal/article/view/929